Showing 2811-2820 of 3738 results for "".
Fine Particulate Matter and Eczema
https://practicaldermatology.com/issues/july-2025/fine-particulate-matter-and-eczema/36512/The primary objective of this study was to investigate the potential associations between fine particulate matter (specifically PM2.5) exposure and eczema. Researchers on this study set out to explore whether the odds of having eczema would increase with greater PM2.5 exposure, and to identify whethCan AI and Digital Innovation Improve the Patient Experience?
https://practicaldermatology.com/topics/practice-management/can-ai-and-digital-innovation-improve-the-patient-experience/23964/Embrace AI and how it can help improve points of contact with your patients.Miliary Osteoma Cutis: An Unusual, Sudden-Onset Presentation of a Rare Eruption; Call for Cases
https://practicaldermatology.com/youngmd-connect/resident-resource-center/miliary-osteoma-cutis-an-unusual-sudden-onset-presentationof-a-rare-eruption-call-for-cases/23067/Update on UV Safety
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-uv-safety/23632/The facts about recent developments in sunscreen and strategies for patient safety.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/22964/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21587/Diagnosis: “Brochure-itis”
https://practicaldermatology.com/topics/practice-management/diagnosis-brochure-itis/21604/You can make over practice websites with simple edits.Combination Biologic and GLP-1 Receptor Agonist Therapy in Psoriasis
https://practicaldermatology.com/topics/psoriasis/combination-biologic-and-glp-1-receptor-agonist-therapy-in-psoriasis/60858/New evidence indicates benefits of a dual-treatment strategy for many patients.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivExploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/topics/general-topics/exploring-the-connection-between-gut-health-and-hair-1/23110/